Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Feb 15;314(Pt 1):277–284. doi: 10.1042/bj3140277

Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by gamma radiolysis: a comparison with low-density lipoprotein.

J L Beaudeux 1, M Gardes-Albert 1, J Delattre 1, A Legrand 1, F Rousselet 1, J Peynet 1
PMCID: PMC1217037  PMID: 8660295

Abstract

Lipid peroxidation of lipoprotein(a) [Lp(a)] by defined oxygen-centred free radicals (O2-/OH, O2-, O2-/HO2) produced by gamma radiolysis was compared with that of paired samples of low-density lipoprotein (LDL). Lp(a) appeared to be more resistant to oxidation than LDL, as indicated by the kinetic study of four markers of lipid peroxidation; decrease in vitamin E, formation of conjugated dienes and aldehydic products, and modification of electrophoretic mobility. In contrast, similar kinetics of lipid peroxidation were obtained for LDL and Lp(a-), which is the lipoparticle issued following the reductive cleavage of apolipoprotein(a) from Lp(a), thus suggesting that the greater resistance of Lp(a) to lipid peroxidation was due to the presence of apolipoprotein(a). Lipid peroxidation of Lp(a) and LDL induced by peroxyl radicals, which were produced by an azo compound [2,2'-azobis-(2-amidinopropane)dihydrochloride], confirmed both the resistance of Lp(a) to lipid peroxidation and the propensity of Lp(a-) to exhibit a greater susceptibility to oxidation than intact Lp(a). Our findings also indicated that the high content of apolipoprotein(a) in N-acetylneuraminic acid residues was only partly responsible for the resistance of Lp(a) to oxidation.

Full Text

The Full Text of this article is available as a PDF (469.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong V. W., Walli A. K., Seidel D. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res. 1985 Nov;26(11):1314–1323. [PubMed] [Google Scholar]
  2. Babiy A. V., Gebicki J. M., Sullivan D. R. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis. 1990 Apr;81(3):175–182. doi: 10.1016/0021-9150(90)90064-p. [DOI] [PubMed] [Google Scholar]
  3. Bedwell S., Dean R. T., Jessup W. The action of defined oxygen-centred free radicals on human low-density lipoprotein. Biochem J. 1989 Sep 15;262(3):707–712. doi: 10.1042/bj2620707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bihari-Varga M., Gruber E., Rotheneder M., Zechner R., Kostner G. M. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis. 1988 Nov-Dec;8(6):851–857. doi: 10.1161/01.atv.8.6.851. [DOI] [PubMed] [Google Scholar]
  5. Bonnefont-Rousselot D., Gardès-Albert M., Delattre J., Ferradini C. Oxidation of low-density lipoproteins by OH. and OH./O2-. free radicals produced by gamma radiolysis. Radiat Res. 1993 Jun;134(3):271–282. [PubMed] [Google Scholar]
  6. Bonnefont-Rousselot D., Gardès-Albert M., Lepage S., Delattre J., Ferradini C. Effect of pH on low-density lipoprotein oxidation by O2-./HO2. free radicals produced by gamma radiolysis. Radiat Res. 1992 Nov;132(2):228–236. [PubMed] [Google Scholar]
  7. Catignani G. L., Bieri J. G. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem. 1983 Apr;29(4):708–712. [PubMed] [Google Scholar]
  8. Cominacini L., Garbin U., Cenci B., Davoli A., Pasini C., Ratti E., Gaviraghi G., Lo Cascio V., Pastorino A. M. Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans. Clin Chim Acta. 1991 Dec 31;204(1-3):57–68. doi: 10.1016/0009-8981(91)90217-z. [DOI] [PubMed] [Google Scholar]
  9. Esterbauer H., Dieber-Rotheneder M., Waeg G., Puhl H., Tatzber F. Endogenous antioxidants and lipoprotein oxidation. Biochem Soc Trans. 1990 Dec;18(6):1059–1061. doi: 10.1042/bst0181059. [DOI] [PubMed] [Google Scholar]
  10. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jürgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 1990 Mar-Apr;3(2):77–92. doi: 10.1021/tx00014a001. [DOI] [PubMed] [Google Scholar]
  11. Fless G. M., Rolih C. A., Scanu A. M. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem. 1984 Sep 25;259(18):11470–11478. [PubMed] [Google Scholar]
  12. Fless G. M., ZumMallen M. E., Scanu A. M. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). J Biol Chem. 1986 Jul 5;261(19):8712–8718. [PubMed] [Google Scholar]
  13. Gaubatz J. W., Ghanem K. I., Guevara J., Jr, Nava M. L., Patsch W., Morrisett J. D. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res. 1990 Apr;31(4):603–613. [PubMed] [Google Scholar]
  14. Haberland M. E., Fless G. M., Scanu A. M., Fogelman A. M. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. J Biol Chem. 1992 Feb 25;267(6):4143–4151. [PubMed] [Google Scholar]
  15. Jackson R. L., Ku G., Thomas C. E. Antioxidants: a biological defense mechanism for the prevention of atherosclerosis. Med Res Rev. 1993 Mar;13(2):161–182. doi: 10.1002/med.2610130204. [DOI] [PubMed] [Google Scholar]
  16. Jürgens G., Ashy A., Esterbauer H. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochem J. 1990 Jan 15;265(2):605–608. doi: 10.1042/bj2650605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Keesler G. A., Li Y., Skiba P. J., Fless G. M., Tabas I. Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor. Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity. Arterioscler Thromb. 1994 Aug;14(8):1337–1345. doi: 10.1161/01.atv.14.8.1337. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. McLean J. W., Tomlinson J. E., Kuang W. J., Eaton D. L., Chen E. Y., Fless G. M., Scanu A. M., Lawn R. M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987 Nov 12;330(6144):132–137. doi: 10.1038/330132a0. [DOI] [PubMed] [Google Scholar]
  20. Naruszewicz M., Selinger E., Davignon J. Oxidative modification of lipoprotein(a) and the effect of beta-carotene. Metabolism. 1992 Nov;41(11):1215–1224. doi: 10.1016/0026-0495(92)90012-y. [DOI] [PubMed] [Google Scholar]
  21. Niki E. Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol. 1990;186:100–108. doi: 10.1016/0076-6879(90)86095-d. [DOI] [PubMed] [Google Scholar]
  22. Pryor W. A., Castle L. Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol. 1984;105:293–299. doi: 10.1016/s0076-6879(84)05037-0. [DOI] [PubMed] [Google Scholar]
  23. Rader D. J., Mann W. A., Cain W., Kraft H. G., Usher D., Zech L. A., Hoeg J. M., Davignon J., Lupien P., Grossman M. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest. 1995 Mar;95(3):1403–1408. doi: 10.1172/JCI117794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sattler W., Kostner G. M., Waeg G., Esterbauer H. Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins. Biochim Biophys Acta. 1991 Jan 4;1081(1):65–74. doi: 10.1016/0005-2760(91)90251-c. [DOI] [PubMed] [Google Scholar]
  25. Scanu A. M. Lipoprotein(a). A genetic risk factor for premature coronary heart disease. JAMA. 1992 Jun 24;267(24):3326–3329. doi: 10.1001/jama.267.24.3326. [DOI] [PubMed] [Google Scholar]
  26. Seman L. J., Breckenridge W. C. Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). Biochem Cell Biol. 1986 Oct;64(10):999–1009. doi: 10.1139/o86-133. [DOI] [PubMed] [Google Scholar]
  27. Snyder M. L., Polacek D., Scanu A. M., Fless G. M. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. J Biol Chem. 1992 Jan 5;267(1):339–346. [PubMed] [Google Scholar]
  28. Stocker R., Bowry V. W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1646–1650. doi: 10.1073/pnas.88.5.1646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Utermann G., Menzel H. J., Kraft H. G., Duba H. C., Kemmler H. G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987 Aug;80(2):458–465. doi: 10.1172/JCI113093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Utermann G. The mysteries of lipoprotein(a). Science. 1989 Nov 17;246(4932):904–910. doi: 10.1126/science.2530631. [DOI] [PubMed] [Google Scholar]
  31. Williams K. J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995 May;15(5):551–561. doi: 10.1161/01.atv.15.5.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 1976 Apr;15(2):212–216. doi: 10.1016/0006-2944(76)90049-1. [DOI] [PubMed] [Google Scholar]
  33. Zioncheck T. F., Powell L. M., Rice G. C., Eaton D. L., Lawn R. M. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest. 1991 Mar;87(3):767–771. doi: 10.1172/JCI115079. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES